ALT: the liver enzyme that leaks when cells are under stress

What ALT actually is and where it comes from

ALT is an enzyme concentrated in liver cells that catalyzes a transfer reaction between the amino acid alanine and alpha-ketoglutarate, feeding glucose production and nitrogen handling. Because it lives primarily in the liver's cytosol, it is more liver-specific than its cousin AST, though muscle contributes a small amount. When liver cells are stressed or injured, ALT leaks into the bloodstream — and that leakage is what a blood test measures.

The liver biology behind your ALT number

ALT rises when liver cell membranes become leaky or damaged. Importantly, it does not measure the liver's functional capacity — it measures cell membrane leakiness. The bump can be short-lived after a viral illness or a heavy drinking weekend, or it can persist with chronic processes like metabolic dysfunction–associated steatotic liver disease (MASLD, formerly NAFLD), autoimmune hepatitis, or certain genetic conditions.

Intense exercise can nudge ALT upward for a few days as muscles and liver adapt, especially with a new or heavy workload. Sleep debt and insulin resistance push the liver toward fat storage and oxidative stress, which can keep ALT elevated over time. Observational studies also link chronically higher ALT — even within some "normal" ranges — to higher risk of type 2 diabetes and cardiovascular disease, largely because ALT is a proxy for liver fat and inflammation. On the other side, very low ALT in older adults has been associated with frailty and higher mortality in some cohorts, likely reflecting low muscle mass and diminished physiologic reserve.

One methodological note: some assays add vitamin B6 (the ALT cofactor) to normalize results; labs that omit it may return slightly different values, which matters when comparing results across different laboratories.

Low, normal, and high ALT explained

Normal

Many labs still list an upper limit around 40 U/L, but studies that excluded people with unrecognized liver and metabolic conditions suggest healthier cutoffs may be lower for many adults and differ by sex. Several expert groups highlight that men tend to run higher than women, with sex-specific optimal thresholds often cited around 29–33 U/L for men and 19–25 U/L for women. A result within the standard reference range is not automatically a clean bill of liver health if it sits near the top, and a mild bump above range is not a diagnosis. Labs use different methods, and age, body composition, and pregnancy all change the context. Use ALT as a signal to look closer at patterns, not as a verdict.

High

Elevated ALT often reflects liver cell irritation from common, addressable causes. Insulin resistance and visceral fat can load the liver with fat droplets, generate oxidative stress, and nudge ALT higher. Alcohol can do the same, especially with binge patterns. Viral infections — from a simple cold to hepatitis — may transiently raise ALT. Medications and supplements matter too: acetaminophen in high doses, isoniazid, some antibiotics, and rare reactions to botanicals like concentrated green tea extracts have all been implicated. Rapid weight loss may temporarily shift ALT as fat mobilizes.

Less common causes include autoimmune liver disease, hemochromatosis (iron overload), Wilson disease (copper accumulation), and alpha-1 antitrypsin deficiency. Pregnancy-related conditions such as preeclampsia or HELLP require immediate medical evaluation if ALT spikes with symptoms. Hard training can also lift ALT for a short window, especially alongside AST, with values normalizing over several days.

Context sharpens the picture. A higher AST-to-ALT ratio can point toward alcohol-related injury or muscle contribution. GGT tends to track cholestatic stress and alcohol exposure. Persistence across repeat tests and correlation with symptoms matter far more than a single outlier.

Low

Low ALT is not automatically better. In older adults, very low values sometimes correlate with low muscle mass or frailty, reflecting less enzyme production overall rather than exceptional liver health. Some assay methods require the vitamin B6 cofactor; if a lab omits it, low B6 status can artifactually reduce the measured ALT result. Long-term dialysis and advanced liver scarring can also yield lower values because fewer active liver cells are producing the enzyme.

In most healthy people, a low ALT within the reference range is simply normal. The key is fit: does the result match your story, your body composition, and your other labs? If not, it is worth exploring nutrition, training status, and potential assay differences with your clinician.

Why ALT results drift between draws

Several factors can shift ALT independently of underlying liver disease, making it important to interpret any single result in context.

• Alcohol: Even moderate binge patterns increase oxidative stress in liver cells and can raise ALT within days of exposure.
• Insulin resistance and visceral fat (MASLD): Chronic fat accumulation in the liver is one of the most common drivers of persistently elevated ALT in otherwise healthy-seeming adults.
• Intense exercise: A hard training session or race can transiently spike ALT alongside AST and creatine kinase; pairing all three helps separate a muscle-derived blip from a liver signal. Values typically normalize within several days.
• Sleep debt and obstructive sleep apnea (OSA): Poor sleep raises cortisol and sympathetic tone, promoting liver fat storage. Intermittent hypoxia from OSA is a potent driver of liver fat and inflammation and has been linked to higher ALT in clinical studies.
• Medications: Acetaminophen at high doses, isoniazid, some antibiotics, and statins can all affect ALT. Most statin-related rises are mild and reversible, and liver society guidelines note statins are generally safe in metabolic liver disease — individual decisions belong with your clinician. Concentrated botanical supplements marketed for "detox" can also inflame the liver and raise ALT.
• GLP-1–based therapies: Trials of weight-loss strategies and GLP-1–based therapies show ALT reductions alongside decreased liver fat, though these medications should be considered only in partnership with a clinician and are not approved solely for this purpose.
• Pregnancy: Liver physiology changes during pregnancy, and conditions such as preeclampsia or HELLP carry their own differential for enzyme elevation.
• Vitamin B6 and assay variation: ALT's enzyme activity depends on vitamin B6 as a cofactor. Labs that do not add B6 to the assay may return lower values in people with marginal B6 status, making cross-lab comparisons less straightforward.

Markers that read ALT in context

ALT is most informative when read alongside other markers. No single enzyme tells the full liver story.

• AST (aspartate aminotransferase) — the AST-to-ALT ratio distinguishes liver-specific injury (ALT dominant) from alcohol-related or muscle-contributed elevation (AST dominant, ratio > 2); always pair these two.
• GGT (gamma-glutamyl transferase) — GGT rises with biliary stress and alcohol exposure; when ALT and GGT are both elevated, the liver metabolic or cholestatic pattern becomes more specific.
• ALP (alkaline phosphatase) — if ALP rises alongside ALT with GGT, the cholestatic pathway enters the differential; ALP and GGT elevated with only modest ALT suggests a bile-duct origin over hepatocellular injury.
• hs-CRP (high-sensitivity C-reactive protein) — hs-CRP adds the inflammatory backdrop; elevated ALT alongside elevated hs-CRP supports a metabolic or inflammatory liver pattern rather than isolated enzyme elevation.
• ApoB (apolipoprotein B) — ApoB connects liver metabolic dysfunction (MASLD) to atherogenic particle burden; rising ALT alongside rising ApoB signals systemic cardiometabolic risk driven by the same root cause.

When to retest your ALT after a change

ALT has a short half-life in blood — values can shift within days of an acute exposure such as a drinking episode or a hard training block. That sensitivity is useful, but it also means a single draw can reflect noise rather than signal. Trends over 8–12 weeks are what separate meaningful change from transient fluctuation.

If you are actively working to bring down an elevated result — through weight loss, alcohol cessation, or MASLD management — retest at 8–12 weeks. Clinical trials show 20–40% ALT reductions within 12 weeks with sustained lifestyle change, so that window is long enough to detect a real response without waiting so long that you lose the feedback loop.

For stable maintenance, an annual retest is a reasonable cadence for most adults. When retesting, avoid intense exercise in the 48 hours before your draw to prevent a muscle-derived spike from confounding the liver signal. Use the same laboratory and the same morning fasting protocol where possible, so that assay method and timing do not introduce artificial variation between draws.

When ALT results warrant a clinician's review

Because the liver is quiet until it is not, ALT gives early feedback on how your metabolism, alcohol pattern, sleep, and medications are landing in the real world. Most mild, isolated elevations resolve with lifestyle change and a follow-up draw. But certain patterns call for prompt clinical attention:

• ALT persistently elevated across two or more draws separated by weeks, without an obvious transient cause
• ALT more than three times the upper limit of normal
• Elevation accompanied by symptoms — jaundice, right-upper-quadrant pain, dark urine, unexplained fatigue, or swelling
• Rising ALT alongside abnormal bilirubin, low albumin, or a prolonged INR, which may signal impaired liver synthetic function
• Any ALT spike during pregnancy, particularly with headache, hypertension, or thrombocytopenia
• New or recently changed medications with a known hepatotoxic profile

Trended over time, ALT becomes a compass: you make a change, you watch what happens, you adjust. Pair it with the companion markers above, with how you feel, and with the habits you are building. A comprehensive biomarker panel — one that brings ALT together with metabolism, inflammation, lipid, and kidney markers — turns scattered dots into a coherent story and supports informed decisions made in collaboration with qualified clinicians. That is prevention and personalization in action.

Join Superpower today to access advanced biomarker testing with over 100 biomarkers.